Revolution Medicines Inc (RVMD)
40.20
+1.00
(+2.56%)
USD |
NASDAQ |
May 03, 16:00
40.20
0.00 (0.00%)
After-Hours: 19:19
Revolution Medicines Enterprise Value: 4.601B for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 4.601B |
| May 01, 2024 | 4.540B |
| April 30, 2024 | 4.287B |
| April 29, 2024 | 4.259B |
| April 26, 2024 | 4.069B |
| April 25, 2024 | 3.966B |
| April 24, 2024 | 4.008B |
| April 23, 2024 | 4.119B |
| April 22, 2024 | 4.147B |
| April 19, 2024 | 3.898B |
| April 18, 2024 | 4.048B |
| April 17, 2024 | 4.211B |
| April 16, 2024 | 4.117B |
| April 15, 2024 | 4.000B |
| April 12, 2024 | 4.087B |
| April 11, 2024 | 4.308B |
| April 10, 2024 | 4.158B |
| April 09, 2024 | 3.580B |
| April 08, 2024 | 3.402B |
| April 05, 2024 | 3.297B |
| April 04, 2024 | 3.111B |
| April 03, 2024 | 3.317B |
| April 02, 2024 | 3.239B |
| April 01, 2024 | 3.364B |
| March 28, 2024 | 3.455B |
| Date | Value |
|---|---|
| March 27, 2024 | 3.371B |
| March 26, 2024 | 3.088B |
| March 25, 2024 | 3.147B |
| March 22, 2024 | 3.231B |
| March 21, 2024 | 3.488B |
| March 20, 2024 | 3.272B |
| March 19, 2024 | 3.220B |
| March 18, 2024 | 3.243B |
| March 15, 2024 | 3.389B |
| March 14, 2024 | 3.414B |
| March 13, 2024 | 3.623B |
| March 12, 2024 | 3.672B |
| March 11, 2024 | 3.569B |
| March 08, 2024 | 3.458B |
| March 07, 2024 | 3.340B |
| March 06, 2024 | 3.233B |
| March 05, 2024 | 3.078B |
| March 04, 2024 | 3.005B |
| March 01, 2024 | 3.055B |
| February 29, 2024 | 3.002B |
| February 28, 2024 | 3.081B |
| February 27, 2024 | 3.190B |
| February 26, 2024 | 3.150B |
| February 23, 2024 | 3.045B |
| February 22, 2024 | 2.931B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
560.77M
Minimum
May 12 2022
4.601B
Maximum
May 02 2024
1.833B
Average
1.650B
Median
Jun 10 2020
Enterprise Value Benchmarks
| Cutera Inc | 326.38M |
| BioSig Technologies Inc | 19.66M |
| TRACON Pharmaceuticals Inc | -4.446M |
| Zentalis Pharmaceuticals Inc | 305.56M |
| Day One Biopharmaceuticals Inc | 1.169B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -161.54M |
| Revenue (Quarterly) | 0.742M |
| Total Expenses (Quarterly) | 180.72M |
| EPS Diluted (Quarterly) | -1.21 |
| Profit Margin (Quarterly) | -21.77K% |
| Earnings Yield | -9.55% |
| Normalized Earnings Yield | -9.553 |